Does levodopa have a disease-modifying effect in Parkinson's disease? Evidence from a delayed-start trial
Mov Disord
.
2019 Jun;34(6):820.
doi: 10.1002/mds.27686.
Epub 2019 Apr 8.
Authors
Gaetano Barbagallo
1
,
Aldo Quattrone
2
3
Affiliations
1
Institute of Neurology, University Magna Graecia, Catanzaro, Italy.
2
Neuroscience Research Centre, University Magna Graecia, Catanzaro, Italy.
3
Neuroimaging Unit, IBFM, National Research Council, Catanzaro, Italy.
PMID:
30958571
DOI:
10.1002/mds.27686
No abstract available
Keywords:
Parkinson's disease; disease progression; disease-modifying therapy; levodopa.
Publication types
Comment
MeSH terms
Antiparkinson Agents
Carbidopa
Humans
Levodopa*
Parkinson Disease*
Substances
Antiparkinson Agents
Levodopa
Carbidopa